DEK and cancer: In this context, the present results showing that PG545 sequesters DEK in the extracellular space, thereby disrupting DEK internalization, nuclear trafficking and interaction with RAD51-containing complexes, might provide a means of targeting this oncoprotein in additional cancers beyond OC.